Showing results (601-610 of 3,150) with videos related to

Sort By:
Pageof 315
Neuro-Oncology|January 31, 2006
Descriptive epidemiology of vestibular schwannomasJennifer M Propp, Bridget J McCarthy, Faith G Davis, et al.
Neuro-Oncology|January 31, 2006
Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomasGaurav D Shah, Santosh Kesari, Ronghui Xu, et al.
Neuro-Oncology|January 31, 2006
Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-0021H Ian Robins, M Won, Wendy F Seiferheld, et al.
Neuro-Oncology|January 31, 2006
Efficacy of vincristine and etoposide with escalating cyclophosphamide in poor-prognosis pediatric brain tumorsDavid S Ziegler, Richard J Cohn, Geoffrey McCowage, et al.
Neuro-Oncology|May 8, 2014
Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomasMatthias A Karajannis, Geneviève Legault, Michael J Fisher, et al.
Neuro-Oncology|March 1, 2021
A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastomaPaul D Brown, Caroline Chung, Diane D Liu, et al.
Neuro-Oncology|November 9, 2021
Volumetric measurements are preferred in the evaluation of mutant IDH inhibition in non-enhancing diffuse gliomas: Evidence from a phase I trial of ivosidenibBenjamin M Ellingson, Grace Hyun J Kim, Matt Brown, et al.
Neuro-Oncology|October 26, 2012
Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatmentsRoberta Rudà, Lorenzo Bello, Hugues Duffau, et al.
Neuro-Oncology|October 26, 2012
Thromboembolic disease in patients with high-grade gliomaJames R Perry
Neuro-Oncology|November 2, 2012
Overexpression of isocitrate dehydrogenase mutant proteins renders glioma cells more sensitive to radiationSichen Li, Arthur P Chou, Weidong Chen, et al.
Pageof 315